Neurology. 2004 Jun 8;62(11):2098-100
Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME.
Dalhousie University, Halifax, Nova Scotia, Canada.
To estimate the patterns and prevalence of cannabis use among patients with multiple sclerosis (MS), 220 patients were surveyed in Halifax, Nova Scotia.
Seventy-two subjects (36%) reported ever having used cannabis for any purpose; 29 respondents (14%) reported continuing use of cannabis for symptom treatment.
Medical cannabis use was associated with male gender, tobacco use, and recreational cannabis use.
The symptoms reported by medical cannabis users to be most effectively relieved were stress, sleep, mood, stiffness/spasm, and pain.